All News #Library
Others
Kashiv Strengthens Leadership with New Chief Operating Officer
14 Apr 2026 //
BUSINESSWIRE
Kashiv Biosciences, Intas Pharma Ink Exclusive Deal For Complex
09 Feb 2026 //
PHARMIWEB
Kashiv Biosciences To Present At J.P. Morgan Healthcare Conf
06 Jan 2026 //
BUSINESSWIRE
Kashiv BioSciences Gets $150M Debt Financing from GoldenTree
07 Apr 2025 //
BUSINESSWIRE
Kashiv Bio Gets Health Canada Approval For Pegfilgrastim
25 Feb 2025 //
BUSINESSWIRE
Kashiv Biosciences Expands Leadership Team with CFO & CLO
10 Dec 2024 //
BUSINESSWIRE
Kashiv BioSciences Appoints Dr. Sandeep Nilkanth Athalye as CEO
01 Nov 2024 //
BUSINESSWIRE
Kashiv Completes Phase III Enrollment For ADL018, XOLAIR Biosimilar
25 Jul 2024 //
BUSINESSWIRE
Kashiv Biosciences Achieves Second U.S. Biosimilar Approval with FYLNETRA
31 May 2022 //
BUSINESSWIRE
Kashiv Bio Bags Approval for Its First Biosimilar RELEUKOTM (filgrastim-ayow)
02 Mar 2022 //
BUSINESSWIRE
Amneal Completes Acquisition of Kashiv Specialty Pharmaceuticals
05 Apr 2020 //
BIOSPACE

Market Place
Sourcing Support